{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T17:49:25Z","timestamp":1771264165507,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.ijcard.2016.08.293","type":"journal-article","created":{"date-parts":[[2016,8,24]],"date-time":"2016-08-24T05:27:28Z","timestamp":1472016448000},"page":"891-897","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Intravenous \u03b2-blockers for patients undergoing primary percutaneous coronary intervention: A meta-analysis of randomized trials"],"prefix":"10.1016","volume":"223","author":[{"given":"Islam Y.","family":"Elgendy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akram Y.","family":"Elgendy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed N.","family":"Mahmoud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hend","family":"Mansoor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad K.","family":"Mojadidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony A.","family":"Bavry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2016.08.293_bb0005","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1093\/eurheartj\/ehs215","article-title":"ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation","volume":"33","author":"Steg","year":"2012","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2016.08.293_bb0010","doi-asserted-by":"crossref","first-page":"e78","DOI":"10.1016\/j.jacc.2012.11.019","article-title":"2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"61","author":"O'Gara","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2016.08.293_bb0015","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1056\/NEJMoa1208200","article-title":"Door-to-balloon time and mortality among patients undergoing primary PCI","volume":"369","author":"Menees","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2016.08.293_bb0020","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1161\/01.CIR.59.1.113","article-title":"Enzymatic indices of myocardial necrosis: influence on short- and long-term prognosis after myocardial infarction","volume":"59","author":"Thompson","year":"1979","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2016.08.293_bb0025","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/S0735-1097(84)80282-X","article-title":"Enhancement of salvage of reperfused myocardium by early beta-adrenergic blockade (timolol)","volume":"3","author":"Hammerman","year":"1984","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2016.08.293_bb0030","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1161\/01.CIR.56.5.794","article-title":"Infarct size reduction by propranolol before and after coronary ligation in dogs","volume":"56","author":"Rasmussen","year":"1977","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2016.08.293_bb0035","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0033-0620(85)80003-7","article-title":"Beta blockade during and after myocardial infarction: an overview of the randomized trials","volume":"27","author":"Yusuf","year":"1985","journal-title":"Prog. Cardiovasc. Dis."},{"key":"10.1016\/j.ijcard.2016.08.293_bb0040","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2174\/1574890109666140901144210","article-title":"Beta-blockers in the management of coronary artery disease: are we on the verge of a new paradigm shift?","volume":"9","author":"Elgendy","year":"2014","journal-title":"Recent Pat. Cardiovasc. Drug Discov."},{"key":"10.1016\/j.ijcard.2016.08.293_bb0045","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJM198401053100103","article-title":"Reduction of infarct size with the early use of timolol in acute myocardial infarction","volume":"310","year":"1984","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2016.08.293_bb0050","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1161\/01.CIR.83.2.422","article-title":"Immediate versus deferred beta-blockade following thrombolytic therapy in patients with acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) II-B Study","volume":"83","author":"Roberts","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2016.08.293_bb0055","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/S0140-6736(05)67661-1","article-title":"Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial","volume":"366","author":"Chen","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2016.08.293_bb0060","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.amjmed.2014.02.009","article-title":"Beta-blocker use in ST-segment elevation myocardial infarction in the reperfusion era (GRACE)","volume":"127","author":"Park","year":"2014","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ijcard.2016.08.293_bb0065","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1016\/j.jacc.2003.10.068","article-title":"Impact of intravenous beta-blockade before primary angioplasty on survival in patients undergoing mechanical reperfusion therapy for acute myocardial infarction","volume":"43","author":"Halkin","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2016.08.293_bb0070","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S0002-9149(02)03401-X","article-title":"Effects of prior beta-blocker therapy on clinical outcomes after primary coronary angioplasty for acute myocardial infarction","volume":"91","author":"Harjai","year":"2003","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcard.2016.08.293_bb0075","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1016\/j.jacc.2016.03.522","article-title":"Early administration of intravenous beta-blockers in patients with ST-elevation myocardial infarction before primary PCI","volume":"67","author":"Roolvink","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2016.08.293_bb0080","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jcin.2015.10.035","article-title":"Randomized control of sympathetic drive with continuous intravenous esmolol in patients with acute ST-segment elevation myocardial infarction: the BEtA-Blocker Therapy in Acute Myocardial Infarction (BEAT-AMI) Trial","volume":"9","author":"Er","year":"2016","journal-title":"JACC Cardiovasc. Interv."},{"key":"10.1016\/j.ijcard.2016.08.293_bb0085","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1161\/CIRCULATIONAHA.113.003653","volume":"128","author":"Ibanez","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2016.08.293_bb0090","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1253\/circj.CJ-11-0947","article-title":"Randomized study on the efficacy and safety of landiolol, an ultra-short-acting \u03b21-adrenergic blocker, in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention","volume":"76","author":"Hanada","year":"2012","journal-title":"Circ. J."},{"key":"10.1016\/j.ijcard.2016.08.293_bb0095","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/2046-4053-1-2","article-title":"The nuts and bolts of PROSPERO: an international prospective register of systematic reviews","volume":"1","author":"Booth","year":"2012","journal-title":"Syst. Rev."},{"key":"10.1016\/j.ijcard.2016.08.293_bb0100","doi-asserted-by":"crossref","DOI":"10.1067\/mhj.2002.126114","article-title":"Esmolol in acute ischemic syndromes","volume":"144","author":"Mitchell","year":"2002","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ijcard.2016.08.293_bb0105","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.ijcard.2016.08.293_bb0110","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1136\/bmj.323.7303.42","article-title":"Systematic reviews in health care: assessing the quality of controlled clinical trials","volume":"323","author":"Juni","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/j.ijcard.2016.08.293_bb0115","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control. Clin. Trials"},{"key":"10.1016\/j.ijcard.2016.08.293_bb0120","doi-asserted-by":"crossref","first-page":"d4002","DOI":"10.1136\/bmj.d4002","article-title":"Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials","volume":"343","author":"Sterne","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.ijcard.2016.08.293_bb0125","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.ijcard.2016.08.293_bb0130","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1016\/j.jacc.2014.03.014","article-title":"Long-term benefit of early pre-reperfusion metoprolol administration in patients with acute myocardial infarction: results from the METOCARD-CNIC trial (effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction)","volume":"63","author":"Pizarro","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2016.08.293_bb0135","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/S0735-1097(98)00279-4","article-title":"Atenolol use and clinical outcomes after thrombolysis for acute myocardial infarction: the GUSTO-I experience. Global utilization of streptokinase and TPA (alteplase) for occluded coronary arteries","volume":"32","author":"Pfisterer","year":"1998","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2016.08.293_bb0140","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/S0140-6736(84)90651-2","article-title":"Prevention of ventricular fibrillation during acute myocardial infarction by intravenous propranolol","volume":"2","author":"Norris","year":"1984","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2016.08.293_bb0145","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/j.jacc.2003.09.072","article-title":"Sustained ventricular tachycardia or fibrillation in the cardiac catheterization laboratory among patients receiving primary percutaneous coronary intervention: incidence, predictors, and outcomes","volume":"43","author":"Mehta","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2016.08.293_bb0150","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/j.jacc.2016.02.050","article-title":"Impact of the timing of metoprolol administration during STEMI on infarct size and ventricular function","volume":"67","author":"Garc\u00eda-Ruiz","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2016.08.293_bb0155","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1016\/j.jacc.2016.03.532","article-title":"Intravenous beta-blockers for cardioprotection in STEMI: the saga continues","volume":"67","author":"Newby","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2016.08.293_bb0160","first-page":"1227","article-title":"Comparison and co-relation of invasive and noninvasive methods of ejection fraction measurement","volume":"99","author":"Godkar","year":"2007","journal-title":"J. Natl. Med. Assoc."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527316320125?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527316320125?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T20:36:54Z","timestamp":1759091814000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527316320125"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":32,"alternative-id":["S0167527316320125"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2016.08.293","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intravenous \u03b2-blockers for patients undergoing primary percutaneous coronary intervention: A meta-analysis of randomized trials","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2016.08.293","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}